Esketamine and Butorphanol for Post-Lobectomy Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

January 1, 2024

Conditions
EsketaminePainPost-thoracotomy Pain SyndromeThoracic Diseases
Interventions
DRUG

Esketamine

In the esketamine combined with butorphanol group (Group BK), patients received an intraoperative intravenous infusion of esketamine (0.3 mg/kg/h) followed by postoperative patient-controlled intravenous analgesia (PCIA) (esketamine 1.5 mg/kg + butorphanol 0.15 mg/kg + azasetron 20 mg).

DRUG

Butorphanol

In the butorphanol group (Group B), patients received an equivalent volume of normal saline intraoperatively and postoperatively received PCIA without esketamine.

Trial Locations (1)

230011

The Second People's Hospital of Hefei, Hefei

All Listed Sponsors
collaborator

Tongji Hospital

OTHER

lead

Second People's Hospital of Hefei City

OTHER